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Within the Veterans Affairs Health Care System, posttraumatic stress disorder 
(PTSD) is routinely assessed in both mental health settings, including PTSD specialty 
clinics, and medical settings such as polytrauma clinics. To date, no empirical studies 
have been published that investigate the influence of contextual factors on measures 
such as the PTSD Checklist (PCL) when administered in different settings on 
separate, distinct occasions. Further, little is known about the impact on commonly 
used assessment measures when traumatic brain injury (TBI) and PTSD co-occur and 
what, if any, influence contextual factors have on veterans’ endorsement of symptoms 
or their consistency in reporting the shared or overlapping symptoms. The present 
study conducted a systematic evaluation of the influence of measurement context on 
self-reported postconcussive and PTSD symptoms. Specifically, analyses focused on 
the consistency of reported symptoms across questionnaires and settings. Additionally, 
the influence of measurement occasion and context on PTSD symptom reporting 
within medical and mental health contexts was explored.
Data from 713 Operation Enduring Freedom (OEF)/Operation Iraqi Freedom 
(OIF)/Operation New Dawn (OND) veterans was collected from retrospective 
medical chart reviews. Results indicated moderate to strong correlations between 
similar items measuring sleep, concentration, irritability, and loss of interest on the 
PCL, Neurobehavioral Symptom Inventory (NSI), and Patient Health Questionnaire 
(PHQ) and revealed no significant effect of context on item-level reporting. A fixed 
effects repeated measures ANOVA revealed no effect of measurement occasion and 
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a two-period cross-over analysis revealed no evidence of differential carryover (e.g., 
there was no context X occasion interaction). However, the influence of context was 
significant and accounted for 12% of the variance in PCL scores. PCL mean scores 
were higher in the mental health setting (63.64) than the medical setting (58.37).
This is the first study to the author’s knowledge that investigated what, if any, 
differences are noted on PCL scores when administered in contextually different 
settings on distinct measurement occasions. Results suggest that self-reports of the 
severity of PTSD symptoms depend on whether the individual completes the PCL in 
a mental health (PTSD) or medical (polytrauma) context. Given the large numbers 
of recently returning OEF/OIF/OND veterans and the high prevalence rates of co-
occurring PTSD and mild TBI, these results call for continued investigation of the 
reliability of commonly used assessment measures when administered in different 
contexts, and when diagnoses, especially those with many shared symptoms are co-
occurring. Optimizing assessment protocols can help ensure accurate diagnosis and 
effective intervention, ultimately improving the overall quality of care for veterans. 
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INTRODUCTION
Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) 
have received unprecedented public attention and clinical focus since the start of 
the current wars in the Middle East. These conditions have become known as the 
“signature injuries” of these wars due to high prevalence rates among returning 
military service members and veterans (Hoge et al., 2004, Sayer et al., 2008; 
Tanielian & Jaycox, 2008). Despite the vast amounts of empirical literature that have 
accumulated in the past decade examining various aspects of PTSD and TBI, there is 
a notable lack of research that evaluates the utility and effectiveness of commonly used 
assessment measures for these conditions when they co-occur (Carlson et al., 2009; 
Spoont et al., 2013). The assessment of either of these disorders can be challenging 
due to retrospective reporting biases, recall error, potential difficulties linking 
symptoms to specific etiological events (Brenner, Vanderploeg, & Terrio, 2009; 
Carlson et al., 2011; Ulloa, Marx, Vanderploeg, & Vasterling, 2012) and the lack of 
a definitive method to diagnose mild TBI  (mTBI) in the post-acute or chronic phase 
(Vanderploeg & Belanger, 2013). The challenge and complexity increases significantly 
when both PTSD and TBI (particularly mTBI, also referred to as concussion) are 
diagnostic possibilities, as the two often have considerable overlap with respect to both 
etiological event(s) and symptom presentation. 
Determining whether or not an individual currently meets diagnostic 
criteria for PTSD or has a history of TBI is typically possible, although the accurate 
attribution of all current symptoms can be far more complicated (Bryant, 2001; 
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Stein & McCallister, 2009; Ulloa, Marx, Vanderploeg, & Vasterling, 2012). Current 
evidence-based practices to screen for PTSD, a history of mTBI, and persistent 
cognitive, affective, and somatic/sensory symptoms or “postconcussive” symptoms 
(PCS) may be less accurate or effective if and when the conditions co-occur (Carlson 
et al., 2009). Additionally, due to cultural differences in reporting style (Osterman 
& de Jong, 2007) or stigma associated with having a mental health diagnosis (e.g., 
Brenner, Vanderploeg, & Terrio, 2009; Hoge et al., 2004; Kilbourne, Keyser, 
& Pincus, 2010), it is possible that contextual factors relating to the assessment 
instruments and/or measurement environment in which the assessment is being 
conducted may influence veterans’ endorsement of symptoms (Ulloa, Marx, 
Vanderploeg, & Vasterling, 2012). 
This lack of knowledge and evidence raises concern as research suggests that 
the use of valid and reliable assessment measures may not, in and of itself, ensure the 
quality of the data obtained (Bradley et al., 2010; Hawkins et al., 2007). Potentially 
flawed assessment methodology and related poor quality data can have considerable 
consequences for veterans as the diagnoses they are given directly influence the type 
of treatment(s) they receive and treatment prognosis, the compensation and pension 
benefits they are eligible for, and their views and beliefs about themselves. Significant 
consequences also exist for care providers, treatment programs, payers, and other 
stakeholders in the service of providing care and improving outcomes for veterans 
(Kilbourne, Keyser, & Pincus, 2010). The present study examines the influence of 
context (e.g., medical or mental health setting) and overall assessment objective (e.g., 
seemingly medical or mental health-based questions) on veterans’ consistency in 
reporting the, often commingled, symptoms of PTSD and PCS. 
The following literature review provides a brief description of military 
3
background; prevalence rates, definitions, and diagnostic criteria for PTSD, mTBI, 
and PCS; a discussion of the symptom overlap between the conditions; information 
regarding the VA’s integration of mental health services into primary care settings and 
the creation of the Polytrauma System of Care; brief introductions to measurement-
based care and discordance analysis; and a description of the specific research 
questions. 
Military Background 
The ongoing military operations in Iraq and Afghanistan are the first 
sustained ground combat undertaken by the United States since the war in Vietnam. 
Since October 2001, more than two million U.S. military troops have deployed 
to the Middle East in support of Operation Enduring Freedom (OEF; primarily 
in Afghanistan), Operation Iraqi Freedom (OIF; primarily in Iraq) and Operation 
New Dawn (OND; U.S. military involvement in Iraq since September 2010). Many 
of these military troops have been exposed to prolonged periods of intense combat-
related stress and traumatic events and approximately 37% of these service members 
have been deployed two or more times (Litz & Schlenger, 2009; Tanielian & Jaycox, 
2008). High rates of exposure to specific types of combat trauma are common among 
OEF/OIF/OND veterans. Studies suggest between 40% (Tanielian & Jaycox) and 
90% (Hoge et al., 2004) of those deployed to the Middle East report exposure to 
dead bodies and/or receiving enemy fire, and between 50% and 80% report having 
a friend who was seriously injured or killed. The pace and nature of the deployments 
in these current conflicts is unprecedented in the history of our nation’s military 
force (Belasco, 2007; Bruner, 2006). Not only are higher proportions of the armed 
forces being deployed, including Reservists and National Guard, but deployments 
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have been longer, redeployment to combat has been common, and breaks between 
deployments have been infrequent (Hosek, Kavanagh, & Miller, 2006). Further, an 
“urban warfare” setting like many seen across Iraq and Afghanistan can be especially 
stressful and present unique challenges (Hoge et al., 2004; NCPTSD, 2010; Tanielian 
& Jaycox, 2008). Urban warfare is notorious for complicating operational planning, 
command, control, and communications for numerous reasons. Combatants are 
harder to identify, civilians are often densely populated, increasing the risk for civilian 
casualties, and the urban environmental terrain is markedly different from combat in 
a more open and defined theater of operations (Johnson, Markel, & Shannon, 2012). 
Despite extended periods of intense combat, these wars have produced 
significantly lower casualty rates of killed or wounded than in earlier conflicts, such 
as Vietnam, Korea, or the World Wars (Tanielian & Jaycox, 2008). Fewer penetrating 
brain, abdominal, and thoracic injuries are sustained compared to prior conflicts 
(Gondusky & Reiter, 2005). Significant advances in both medical technology and 
accessibility within a combat theater as well as protective body armor mean that 
more service members are surviving injurious experiences that would have been fatal 
in prior wars (Gawande, 2004; Regan, 2004; Warden, 2006). Additionally, there 
has been greater availability for rapid air evacuation in which wounded soldiers are 
transported to near-by military hospitals for life-saving medical procedures (Peoples, 
Gerlinger, Craig, & Berlingame, 2005). Despite sometimes catastrophic injuries, these 
advances in military medicine and response have contributed to the survival of more 
than 90% of the soldiers seriously wounded in OEF/OIF/OND (Gawande, 2004). 
However, casualties of a different kind—“invisible wounds”—such as mental 
health conditions and cognitive impairments that result from deployment experiences 
are emerging at alarming rates (Hoge et al., 2004; Hoge et al., 2008; Kennedy et al., 
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2007; Tanielian & Jaycox, 2008; Walker, Clark, & Sanders, 2010). Evidence suggests 
that the psychological toll of these deployments, many involving prolonged exposure 
to combat-related stress over multiple rotations, may be disproportionately high 
compared with the physical injuries of combat (Hoge et al., 2004; Tanielian & Jaycox, 
2008; Walker et al., 2010).
Prevalence Rates of PTSD and mTBI
The true prevalence of PTSD and mTBI among military service members is 
difficult to estimate. Complications include limitations in real-time documentation 
of war-zone injuries and events, differences in sampling strategies and time frames, 
the ambiguity surrounding the operational definitions of the two conditions, and 
the methods by which they are assessed (Carlson et al., 2011; Vasterling, Bryant, 
& Keane, 2012). Further, in combat, even if the specific event leading to a TBI 
does not precipitate PTSD, the TBI occurs in a context of persistent and repeated 
exposure to extreme psychological stress and/or life threat, which further complicates 
the diagnostic process and accurate attribution of symptoms (Vasterling, Bryant, & 
Keane). 
The prevalence rates of PTSD and mTBI in service members returning from 
OEF/OIF/OND have been reported as 13.8% and 19.5%, respectively (Tanielian 
& Jaycox, 2008). In addition to the occurrence of each condition when considered 
alone, PTSD and mTBI frequently co-occur (Hoge et al., 2008; Tanielian & Jaycox, 
2008; Vasterling, Bryant, & Keane, 2012). Military personnel who experience blast 
exposure and report a history of mTBI are at elevated risk for developing PTSD and/
or depression (Belanger, Kretzmer, Yoash-Gantz, Pickett, & Tupler, 2009; Broomhall 
et al., 2009). Among those veterans reporting a history of mTBI, 27- 44% also 
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screened positive for PTSD (Hoge et al., 2008; Tanielian & Jaycox, 2008). Similarly, 
even without the diagnosis of PTSD, high levels of combat stress are associated with 
a three- to eightfold increase in the rate of reporting of postconcussive-like symptoms 
(Cooper et al., 2011). Eighty-one percent of veterans presenting to a Veterans 
Affairs (VA) Medical Center polytrauma specialty clinic met criteria for more than 
one diagnosis and 42% had three co-occurring diagnoses, including pain, PTSD, 
depression, and PCS (Lew et al., 2009). 
Posttraumatic Stress Disorder
Clinical Definition and Diagnostic Criteria
In its current conceptualization within the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-IV-TR; American Psychiatric Association, 2000) PTSD 
is defined by six criteria. The causal factor (criterion A) of PTSD states that an 
individual must have experienced a traumatic event in which there was perceived 
or actual serious danger or threat to self or others. The need for an external causal 
factor is a unique element to PTSD, not shared with any other disorder in the DSM-
IV-TR. Additionally, criterion A2 states the experience must have evoked strong 
feelings, including intense fear, helplessness, and/or horror. The cardinal signs and 
symptoms of PTSD are currently broadly divided into three symptom clusters, 
including persistent re-experiencing of trauma (a sense of reliving traumatic events 
through intrusive thoughts, memories, nightmares, flashbacks, psychological and 
physiological distress when reminded of aspects of the trauma, etc.; criterion B); 
emotional numbing and avoidance of thinking or talking about past trauma and of 
situations that trigger memories of trauma (criterion C); and heightened arousal and 
hypervigilance (a heightened sense of awareness of one’s surroundings, exaggerated 
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startle response; trouble falling or staying asleep; irritability; criterion D). The typical 
course of PTSD begins with the development of symptoms within 6-months of the 
precipitating traumatic event, although delayed onset is not uncommon. The full 
spectrum of symptoms must be present for more than 1 month (criterion E) and the 
psychological distress must cause clinically significant impairment and debilitating 
behavioral features such as unemployment, impulsive or violent behavior, and family 
discord (criterion F; American Psychiatric Association, 1994; Foa et al., 2000; Kulka 
et al., 1988). 
The DSM-IV-TR has been undergoing revisions and the DSM-5 is slated to 
be released to the general public in May 2013. The DSM-5 PTSD work-group has 
made significant changes to the clinical definition and diagnostic criteria. They have 
paid greater attention to the behavioral symptoms that accompany PTSD, and have 
restructured and recategorized the symptom clusters to include re-experiencing, 
avoidance, negative cognitions and mood, and arousal (American Psychiatric 
Association, 2013; Friedman, Resick, Bryant, & Brewin, 2010; Miller et al., 2012).
Individuals suffering from PTSD also typically experience a diverse set 
of secondary symptoms. Guilt, including survivor guilt and guilt regarding acts 
of omission or commission (King & King, 1994; Kubany, 1994) as well as anger 
(Chemtob, Harnada, Roitblat, & Muraoka, 1994; Kubany, Gino, Denny, & Torigoe, 
1994) are especially common among veterans. Cognitive effects such as impaired 
concentration and decision making, memory impairment, and confusion are also 
frequently reported(Bremner et al., 1992; Brenmer, Krystal, & Charney, 1995; 
Horowitz, 1986). Behavioral symptoms such as increased relational conflict resulting 
in social withdrawal, alienation, reduced relational intimacy, and impaired work 
and school performance are common. Finally, somatic complaints of exhaustion, 
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insomnia, and cardiovascular, gastrointestinal, and musculoskeletal disorders are also 
endorsed by many individuals with PTSD (NCPTSD, 2011).
Risk Factors 
Research has shown that multiple risk factors make some individuals more 
prone to develop PTSD than others (APA, 2000; Foa et al., 2000; Kennedy et al, 
2007). Pretraumatic risk factors include female gender, low socioeconomic status, low 
level of education, low level of intelligence, race (e.g., Hispanic, African American, 
American Indian, and Pacific Islander), abuse in childhood or other adverse childhood 
factors, previous traumatization, and family history of psychiatric disorders. Peri- 
and posttraumatic factors include (1) experience of greater stressor magnitude and 
intensity, unpredictability, uncontrollability, real or perceived responsibility, and 
betrayal; (2) being in a situation of ongoing or persistent stress and exposure to trauma 
(e.g., a combat theater, domestic violence relationship); (3) report of greater perceived 
threat or danger, suffering, upset, terror, horror and/or fear; (4) lack of social support; 
(5) a social environment that produces shame, guilt, stigmatization, or self-hatred; (6) 
young age at the time of exposure to trauma (many military service personnel enter 
the military at 18); (7) poor training or preparation for the traumatic event (e.g., how 
prepared are soldiers for what they face in combat); (8) bereavement or traumatic 
grief (e.g., many returning service personnel report having lost friends and comrades 
during their deployment; loss of self, meaning, purpose in life due to functional 
impairment); (9) major loss of resources (e.g., many veterans are discharged from the 
military and struggle to find or sustain employment; many are disabled and file for 
compensation and pension); (10) children in the home and/or a distressed spouse (e.g., 
many of the service personnel are young men and women with families; deployments, 
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especially multiple deployments can be very hard for the families who remain at home 
as can the readjustment phase postdeployment; (11) history of preexisting psychiatric 
diagnoses and/or substance abuse; (12) poor coping skills; and (13) predisposition due 
to genetic factors (APA, 2000; Foa, Keane, & Friedman, 2000; Kennedy et al., 2007). 
Traumatic Brain Injury
Clinical Definition and Diagnostic Criteria
In the US, the most widely accepted criteria for TBI, and those that are 
supported by the VA and Department of Defense (DoD), are put forth by the 
American Congress of Rehabilitation Medicine (ACRM, 1993). The ACRM defines 
TBI as any traumatically induced structural injury and/or physiological disruption 
of brain function as a result of an external force that is indicated by new onset or 
worsening of at least one of the following clinical signs, immediately following the 
injurious event: any period of loss of or a decreased level of consciousness; any loss of 
memory or posttraumatic amnesia for events immediately before or after the injury; 
any alteration in mental state or alteration in consciousness at the time of the injury 
(confusion, disorientation, slowed thinking, etc.); neurological deficits (weakness, loss 
of balance, changes in vision, praxis, sensory loss, aphasia) that may or may not be 
transient; or intra-cranial lesion. TBI may arise from any physical damage by external 
blunt or penetrating trauma to the head, skull, dura, or brain or from acceleration-
deceleration movement such as whiplash or coup-countercoup, resulting in tearing 
or shearing of nerve fibers and bruising or contusion of the brain against opposite 
sides of the skull (Kennedy et al., 2007; VA/DoD mTBI Clinical Practice Guidelines, 
2009). Scraping of the brain across the rough bony base of the skull can cause 
contusions as well (Kennedy et al.). 
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TBI is categorized by severity into three levels: mild, moderate, and severe, 
based on the length of loss of consciousness, alteration of consciousness, posttraumatic 
amnesia, and/or the results of structural brain imaging. The present study focuses on 
mild TBI only. Acute severity is determined at the time of the injury, and although 
the severity level has prognostic value, it does not necessarily predict the individual’s 
ultimate level of functioning or the number or severity of postconcussive symptoms 
they experience (VA/DoD mTBI Practice Guidelines, 2009). There is substantial 
evidence that the epidemiology, pathophysiology, natural history, and prognosis 
for mTBI are different than for moderate and severe TBI. For example, the VA/
DoD mTBI Clinical Practice Guidelines (2009) note moderate and severe TBI are 
often associated with objective evidence of injury on brain scans or neurological 
examinations and objective deficits on neuropsychological testing, whereas these same 
evaluations are often not definitive in individuals with mTBI. The natural history 
and prognosis of moderate and severe TBI are more directly related to the nature 
and severity of the injury, whereas factors unrelated to the injury (e.g., comorbid 
psychiatric disorders) have been shown to be the strong predictors of symptom 
persistence after mTBI (Brenner, Vanderploeg, & Terrio, 2009; VA/DoD mTBI 
Practice Guidelines, 2009).
Blast Injuries
Research suggests that approximately 75% of combat injuries among OEF/
OIF/OND soldiers result from explosive munitions (Clark et al., 2007; Owens et 
al., 2008; VHA Handbook 1172.1, part 2.a., p.1). Military service members are 
repeatedly exposed to blasts from roadside bombs, improvised explosive devices 
(IEDs), vehicle-born explosive devices (VBEDs), rocket propelled grenades (RPGs), 
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and mortar attacks, in addition to the ‘usual’ risk for injuries such as penetrating 
bullet wounds from fire fights (Owens et al., 2008; Summerall & McAllister, 2010). 
The consequences of blast-related injuries to the brain are controversial (Kennedy et 
al., 2007; Taber, Warden, & Hurley, 2006); however, the mechanism and sequelae of 
brain over-pressurization from blast waves are similar to those in the fluid percussion 
animal models of mTBI (Gurkoff, Giza, & Hovda, 2006). Studies have demonstrated 
that exposure to blast over-pressurization induces ultra-structural and biochemical 
alterations and associated cognitive deficits in rats (Cernak, Wang, Jiang, Bian, & 
Savic, 2001) and pigs (Capehart, 2011) and can produce fatal injuries if severe enough 
and in close enough proximity. The effects of primary blasts most often cause damage 
not only to the brain, but to air-filled organs, such as the lungs and colon, or those 
at air-filled interfaces, such as the tympanic membranes (eardrums) and the eyes 
(DePalma, Burris, Champion, & Hodgson, 2005; Ritenour & Baskin, 2008; Silver, 
McAllister, & Arciniegas, 2009). 
In the absence of a blast wave with a magnitude sufficient to damage the 
internal organs or cause barotrauma associated with dynamic changes in atmospheric 
pressure, the effects of blasts on the brain are somewhat uncertain (DePalma, Burris, 
Champion, & Hodgson, 2005; Ritenour & Baskin, 2008; Silver, McAllister, & 
Arciniegas, 2009). Research suggests, however, that effects of blasts on the brain are 
the same as those involved in brain injuries incurred in other contexts. These blast 
effects include being struck in the head by debris and shrapnel (secondary effect) 
and being struck in the head when thrown into a stationary object (tertiary effect) 
(Warden, 2006). Quaternary effects unique to blast explosion include burns and 
injury due to inhalation of toxic fumes, smoke, and/or dust (Finkel, 2006). Secondary 
and tertiary blast effects are common mechanisms of blast-related TBI in returning 
12
military personnel (Silver et al., 2009). 
A common misconception among many military service members, their loved 
ones, the news media and general public, and even some treatment providers is that 
any exposure to a blast event means that the individual has sustained a TBI. This 
is inaccurate, as exposure to a blast has many potential outcomes and repercussions 
varying significantly in severity. For example, imagine a group of soldiers driving in 
a convoy. One soldier may feel a slight impact from an IED blast three humvees in 
front of his but not experience any injuries whatsoever, including no loss or alteration 
in consciousness. Another soldier two humvees up may be thrown against the side 
of the vehicle, strike his head, feel dazed and confused momentarily and report a 
headache for several hours. A third, in the humvee hit directly by the IED may 
sustain serious physical injuries, experience a loss of consciousness, and have to be 
medivaced for immediate stabilization and intensive medical care. Exposure to a blast 
can have different outcomes based on one’s relative location to the blast, whether or 
not the individual was physically moved or other objects were moved toward them 
as a result of the blast, and whether or not they were wearing protective body armor, 
a helmet, etc. The VA/DoD mTBI Practice Guidelines (2009) note that not all 
individuals exposed to an external force, including blasts, will sustain a TBI; however, 
any person who has a history of such an event and meets the above ACRM diagnostic 
criteria may have sustained a TBI. 
Risk Factors for Military Personnel
Simply being in the military increases the risk of exposure to traumatic injuries 
that could cause TBI given the nature of common work duties, even during peacetime 
(Ommaya, Ommaya, Dannenberg, & Salazar, 1996; Summerall & McAllister, 2010). 
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This reflects the higher-risk activities service members engage in and perhaps increased 
likelihood of risk-taking personality traits among those volunteering for military 
service (Summerall & McAllister). Further, a history of TBI is, in itself, a significant 
risk factor for future brain injury. Research from civilian samples has suggested that 
those with a single TBI are two to three times more likely to sustain a second injury, 
and those who sustain a second are seven to nine times more likely to sustain a third 
(Annegers, Grabow, Kurland, & Laws, 1980). Similar data are not yet available 
for military populations, although clearly, the risk for all injury, including TBI, is 
significantly increased during times of active combat and thus it could be expected 
that a similar pattern would exist (Summerall & McAllister, 2010; Warden et al., 
2005). 
Postconcussive Symptoms
When speaking of TBI, the term “mild” is not intended to describe the impact 
or severity of any persistent PCS. Rather, the term refers only to the initial injurious 
event and injury characteristics such as duration of lost consciousness or posttraumatic 
amnesia, and visibility of injury on brain scans. Although the vast majority of studies 
of both civilian and military populations have indicated that most individuals with 
a mTBI will return to baseline neuropsychological functioning within the 3 months 
postinjury (Alexander, 1995; Belanger, Curtiss, Demery, Lebowitz, & Vanderploeg, 
2005; Belanger & Vanderploeg, 2005; Levin et al., 1987; Schretlen & Shapiro, 2003), 
a subset of these individuals report a persistent constellation of symptoms for many 
months to years after the injury (Benge, Pastorek, & Thornton, 2009; MacGregor, 
Dougherty, Tang, & Galarneau, 2013). It is estimated that 75-90% of all reported 
TBIs among U.S. military personnel are categorized as mild and that approximately 
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90% of these follow a predictable course where soldiers experience few, if any, 
persistent PCS and rarely require any specialized medical treatment. The prevalence 
of persistent PCS following a mTBI varies widely across studies from 18% to 64% 
(Belanger, Curtiss, Demery, Lebowitz, & Vanderploeg, 2005; Binder, Rohling, & 
Larrabee, 1997; Boake et al., 2005; Dikmen, Marhamer, Fann, & Temkin, 2010; 
Terrio et al., 2009; Vanderploeg, Curtiss, Luis, & Salazar, 2007). A recent study of 
National Guard veterans found that even after controlling for adverse deployment/
combat related stressors, such as injury and exposure to blast, those with a history of 
deployment-related mTBI were 2.5 times more likely to endorse multiple PCS when 
assessed approximately 30 months post-deployment, than those without any history 
of brain injury (Vanderploeg, Belanger, Horner, et al. 2012). Interestingly, these same 
PCS were 2.6 times higher among those with non-TBI physical injuries and 3.1 times 
higher among those who had experienced heavy combat, making it quite difficult to 
know what, if any, unique or direct causative effect mTBI has for these symptoms 
above and beyond that of a common stress or injurious effect (Vanderploeg et al., 
2012). 
Most clinicians and researchers agree that common PCS appear in three 
symptom clusters: cognitive, physical/somatic, and emotional/affective. Common 
cognitive symptoms include deficits in memory, attention, and concentration, 
slowed processing speed, impaired executive functioning and poor mental flexibility, 
problems with decision making, planning, and organization. Common physical or 
somatic symptoms include nausea, vomiting, blurred vision, sensitivity to light and/
or sound, fatigue, disordered sleep, dizziness, vertigo, poor balance, impaired motor 
skills, and headache. Common emotional or affective complaints include irritability 
and agitation, anxiety, impulsivity, aggression, fearfulness, worry, interpersonal 
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sensitivity, and depression (Brenner, Vanderploeg, & Terrio, 2009; VA/DoD mTBI 
Practice Guidelines, 2009). 
PCS are generally nonspecific and share many characteristics with a number of 
preexisting or comorbid conditions including PTSD (Foa, Cashman, Jaycox, & Perry, 
1997); depression (Iverson, 2006); outpatients presenting for psychological treatment 
(Fox, Lees-Haley, Ernest, & Dolezal-Wood, 1995); chronic pain (Gasquoine, 2000; 
Iverson & McCracken, 1997); outpatients with minor medical complaints (Lees-
Haley & Brown, 1993); and personal injury litigants (Dunn, Lees-Haley, Brown, 
Williams, & English, 1995). PCS-like symptoms are common and expected 
among deployed soldiers as well (Hoge, 2010). Further, many healthy adults report 
postconcussive-like symptoms such as headaches, irritability, sleep difficulty, and 
memory deficits, which suggest they are relatively common in daily life (Gouvier, 
Uddo-Crane, & Brown, 1988; Iverson & Lange, 2003; Mittenberg, DiGiulio, 
Perrin, & Bass, 1992). From 35.9% to 75.7% of healthy adults report that they have 
experienced postconcussive-like symptoms in the past 2 weeks, and from 2.9% to 
15.5% report more severe symptoms (Iverson & Lange, 2003). 
Symptom Overlap
There is considerable symptom overlap between PTSD and PCS (Brenner, 
Vanderploeg, & Terrio, 2009; Dunn, Julian, Formolo, Green, & Chicoine, 
2011; Stein & McAllister, 2009) which makes assessment conceptually and 
methodologically challenging when both are diagnostic possibilities (Iverson, 2012). 
Other commonly co-occurring diagnoses such as depression, chronic pain, and 
substance use further complicate the clinical presentation, assessment process, and 
diagnostic reliability as they too can have overlapping symptoms or serve to exacerbate 
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or minimize the experience of symptoms (Iverson). Anxiety, hyperarousal (e.g., sleep, 
poor concentration, irritability, sensitivity to noise), anhedonia, and psychogenic 
posttraumatic amnesia symptoms overlap with PCS (Brenner, Vanderploeg, & 
Terrio, 2009; Iverson). Such significant symptom overlap makes it challenging for the 
clinician to accurately diagnosis, especially in cases where a singular etiological event 
is the cause for both potential PTSD and mTBI. Due to the shared nature of many 
of these symptoms, a thorough assessment of symptom onset is necessary and PCS 
should not be attributed to brain injury if they are better explained by pre-existing 
conditions or other comorbid medical, neurological, or psychological causes except 
in cases of an immediate exacerbation of a pre-existing condition (VA/DoD mTBI 
Practice Guidelines, 2009). 
Integrating Primary Care and Mental Health
In 2007, the Veterans Health Administration began a system-wide initiative 
to integrate mental health services and primary care. They noted that mental and 
physical health are interrelated components of overall health and are best treated in 
a coordinated, comprehensive care system (New Freedom Commission on Mental 
Health, 2003; Department of Veterans Affairs, 2004; Post & Van Stone, 2008). 
It has been suggested that the placement of mental health providers in 
primary care clinics provides an alternative treatment access point, which may help 
reduce apprehension associated with candid reports of symptoms, and efforts to seek 
mental health treatment (Cigrang et al., 2011; Tanielian & Jaycox, 2008). Integrated 
care recognizes several aspects: primary care provides opportunities to screen for 
unrecognized disease; mental health and substance abuse conditions are common 
and are often treated by primary care practitioners; patients may prefer treatment in 
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primary care settings; an established relationship with a primary care practitioner 
fosters engagement in and adherence to treatment; and health conditions do not 
always fall neatly into “physical” and “mental health” categories (VHA Handbook 
1160.01, 2008). 
The Polytrauma System of Care
One of the most notable efforts to integrate medical and mental health care 
into a coordinated and comprehensive system came in response to the new generation 
of veterans that returned from the Middle East and presented with complex physical 
injuries and emotional trauma, and the related need for specialized medical care 
and comprehensive rehabilitation. The VA established the Polytrauma System of 
Care, which provides integrated, interdisciplinary care to veterans who present 
with complex clinical presentations, often including TBI and PTSD. These clinics 
are interdisciplinary in nature, often include providers from physical medicine and 
rehabilitation, psychology, psychiatry, occupational therapy, physical therapy, speech 
therapy, case manager, recreational therapy, and sometimes a vocational rehabilitation 
counselor (Walker et al., 2010) and have shown some success in this complex 
population (Batten & Pollack, 2008; Sayer et al., 2008). The term polytrauma has 
been introduced to describe these more complex, multisystem, blast-related injuries 
(Brenner, Vanderpoleg, & Terrio, 2009; VHA Handbook 1171.1). The Veterans 
Health Administration (VHA) describes complex injuries as polytrauma, defined 
as “...two or more injuries to physical regions or organ systems, one of which may 
be life threatening resulting in physical, cognitive, psychological, or psychosocial 
impairments and functional disability” (VHA Handbook 1172.1, part 3.i., p.3). 
18
Measurement-based Care
The influx of attention on the psychological, cognitive, and physical 
consequences of war and combat has resulted in additional health assessments for 
both service members still in theater and those postdeployment as well as substantial 
efforts by the VA to expand both in- and outpatient mental health services (Bryan 
& Morrow, 2011; Carlson et al., 2009; Tanielian & Jaycox, 2008). The full extent 
to which mental health problems are being detected, accurately assessed and 
diagnosed, and appropriately treated in this high-risk population remains unclear. 
Despite the proliferation of evidence-based guidelines for the treatment of many 
psychiatric conditions, the quality of care and the overall effectiveness of these efforts 
is questionable in light of the fact that mental health problems in general, and suicide 
rates in particular, continue to rise (Bryan & Morrow, 2011; Department of the Army, 
2010; Kilbourne, Keyser, & Pincus, 2010; Tanielian & Jaycox, 2008; Vasterling, 
Bryant, & Keane, 2012; Vogt, 2011). 
A 2006 report by the U.S. Institute of Medicine (IOM) documented 
substantial gaps in evidence-based care for mental health conditions, citing poor 
quality assessment and detection, treatment, and follow-up care (IOM, 2006). VA 
Health Services Research & Development Office (HSR&D) performed a systematic 
review of the literature on the assessment and treatment of individuals with a 
history of TBI and PTSD, focusing on three critical areas, including prevalence 
rates, treatment considerations, and the relative accuracy of diagnostic tests used 
for assessing mTBI and PTSD when the two co-occur (Carlson et al., 2009). 
Although the majority of the findings within this report are outside the scope of the 
present study, one of the findings is relevant. Although there has been a spike in the 
literature exploring comorbid mTBI and PTSD due to their high prevalence rates 
19
among returning service members, the group of content experts were unable to find 
any published studies that address the relative accuracy of screening or diagnostic 
tests used to assess the history of symptoms of mTBI or PTSD when the two are 
comorbid (Carlson et al., 2009). Further, despite general agreement among both 
experts and administrators that VA primary care providers should screen for PTSD 
and that specialty PTSD care should be provided in a primary care setting, there has 
been a paucity of research on the clinical utility of PTSD screening and assessment 
instruments in this type of setting. In addition to the movements to provide PTSD 
services in primary care settings, most metropolitan VAs have PTSD Clinical 
Teams (PCTs) that provide comprehensive care for veterans with PTSD, including 
individual, couples, and group psychotherapy, psychiatric assessments, PTSD-related 
psychological evaluations, and medication management. 
It was not until January 2013 that a systematic evaluation was conducted to 
evaluate screening measures for PTSD commonly used in VA primary care settings 
(Spoont et al., 2013). They found that the PTSD Checklist (PCL; Weathers et al., 
1993) is the most widely used instrument and had the relatively largest empirical 
base of literature when compared to other screening instruments. They identified 
eight studies that had investigated the validity of the instrument in a primary care 
setting (Spoont et al.). However, the authors noted that these studies are of limited 
value because the methodology was flawed, the investigators used biased sampling/
recruiting procedures, and the reports failed to include relevant and important 
additional information (Spoont et al.). Additionally, they found that there continues 
to be a marked absence of literature on the validity and utility of the PCL and 
other assessment instruments in the presence of highly prevalent specific psychiatric 
comorbidities and across varying contexts/clinical settings. Further, they found that 
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there is limited evidence regarding potential variation in the performance of screening 
tools by age, gender, or race, and they provided no information about how specific 
psychiatric comorbidities might affect the performance of the screening tools (Spoont 
et al.). Importantly, it is unknown whether reports by veterans differ depending 
on whether they are obtained in medical or mental health settings. Given the high 
prevalence rates of these conditions and the high likelihood that veterans may be 
assessed in multiple settings, including primary care settings, polytrauma clinics, or 
PTSD/mental health clinics, this seems to be a striking oversight. 
Research optimizing the diagnostic accuracy and clinical utility of assessment 
for PTSD, mTBI history, and PCS are of the utmost importance (Carlson et al., 
2009; Iverson, 2012). The use of valid and reliable assessment measures may not, in 
and of itself, ensure the quality of the data obtained if other factors such as the setting 
in which the measure is administered are overlooked (Bradley et al., 2010; Hawkins 
et al., 2007). Potentially flawed assessment methodology and related poor-quality 
data can have considerable consequences for veterans as the diagnoses they are given 
directly influence the type of treatment(s) they receive, compensation and pension 
benefits, and potential self- or social stigma or stereotyping. Significant consequences 
exist too for care providers, treatment programs, payers, and other stakeholders in the 
service of providing care and improving outcomes for veterans (Kilbourne, Keyser, & 
Pincus, 2010). 
Discordance Analysis
In recent years, the VA has enacted new policies to conduct assessments 
and “quality monitoring practices” more frequently for a variety of physical and 
mental health conditions including PTSD, major depressive disorder, and substance 
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disorders (Kilbourne et al., 2010). Veterans are often asked to complete the same 
measure in various settings at multiple time points to track symptom presentations 
and evaluate the type and quality of services received. Two studies have investigated 
the consistency or ‘concordance’ in veterans’ reporting on identical items on an 
alcohol use screening measure when administered in contextually different settings 
and temporally different occasions (Bradley et al., 2011; Hawkins et al., 2007). Both 
studies found significant inconsistency or ‘discordance’ between veterans’ responses 
across settings and over time. Bradley and colleagues found that almost twice as many 
veterans screened positive for alcohol use on a survey screen (11.1%) than on a clinical 
screen (5.7%). Further, of those that screened positive on the survey screen, over 60% 
had discordant results on the clinical screen compared to the only 1.5% who screened 
negative. Hawkins and colleagues found similar results with only 24.6% of veterans 
screening positive for alcohol misuse based on medical record reviews, while 33.4% 
screened positive based on mailed out surveys. 
Some discordance between clinician administered and mailed survey results 
is expected as veterans may be more or less likely to report honestly when sitting 
face-to-face with a provider, depending on their level of rapport, how relevant they 
feel the information may be, the consequences of honest reporting, if a loved one 
is accompanying them to the appointment, etc.  Further, some inconsistency in 
reporting can be due to random measurement error, regression to the mean, or actual 
changes in veterans’ alcohol use from time one to time two (Bradley et al., 2011; 
Hawkins et al., 2007). However, the level of observed discordance between clinical 
and mailed survey alcohol screeners in these two studies was greater than what could 
be easily accounted for by these factors, suggesting contextual factors such as the 
measurement setting can influence veterans’ endorsement of symptoms (Bradley et al., 
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2011; Hawkins et al., 2007). 
Within the VA Health Care System, PTSD is routinely assessed in both 
mental health clinics, including PTSD specialty clinics, and medical settings such 
as polytrauma clinics, yet, to date, no empirical studies have been published that 
investigate the relative accuracy and utility of measures such as the PCL when 
administered in contextually different settings on multiple measurement occasions. 
Influence of Contextual Factors
Due to potential cultural differences in reporting style (Osterman & de Jong, 
2007) or stigma associated with having a mental health diagnosis or brain injury 
(e.g., Brenner, Vanderploeg, & Terrio, 2009; Hoge et al., 2004; Kilbourne, Keyser, 
& Pincus, 2010), it is possible that contextual factors relating to the assessment 
instruments and/or measurement environment in which the assessment is being 
conducted may influence veterans’ endorsement of symptoms (Ulloa, Marx, 
Vanderploeg, & Vasterling, 2012). Additionally, veterans may report symptoms 
differently depending on who is inquiring and the level of rapport between the 
veteran and provider (Iverson, Brooks, Ashton, & Lange, 2010). Veterans also may 
over- or under-report symptoms for financial reasons (e.g., military service-connected 
disability, workers compensation, personal injury litigation), to gain access to 
treatment services, to avoid legal/criminal consequences, or to receive recognition, 
validation, or honor for serving in the military (Elhai, Sweet, Breting, & Kaloupek, 
2012; Iverson, 2012). 
Statement of the Problem
Little is known about the accuracy of commonly used assessment measures 
when TBI and PTSD co-occur (Carlson et al., 2009; Spoont et al., 2013). More 
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specifically, to date no studies have been published that explore the influence of 
contextual factors on measures such as the PCL when administered in different 
settings on separate occasions, and what, if any, influence contextual factors have 
on veterans’ endorsement of symptoms or their consistency in reporting the same/
overlapping symptoms when PTSD and TBI co-occur (Carlson et al., Donnelly et al., 
2008; Iverson, 2012; King et al., 2012). The present study tested for the influence of 
measurement context on self-reported postconcussive and PTSD symptoms and the 
consistency of OEF/OIF/OND veterans’ reports of symptoms on different self-report 
questionnaires within and between medical and mental health contexts.
Research Questions
Question 1
Questions 1a and 1b assessed veterans’ consistency in reporting symptoms 
across two “obviously psychological” measures administered during a single visit to 
a PTSD clinic. Data analysis focused on nearly identical items that assessed sleep,  
concentration, and loss of interest on the PCL and the Patient Health Questionnaire 
(PHQ), a measure of depressive symptoms. 
a. Are symptoms reported consistently across measures (i.e., PCL and PHQ)? 
b. Are symptoms endorsed to a greater or lesser degree based on the 
assessment construct (i.e., PTSD vs. depression)? 
Question 2
Questions 2a and 2b assessed veterans’ consistency in reporting symptoms 
across separate measures administered in a single visit to a polytrauma clinic. Data 
analysis focused on nearly identical items that assessed sleep, concentration, and 
irritability on the PCL, an obviously “psychological measure,” and the NSI, a more 
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“medical measure.” Specific questions are: 
c. Are symptoms reported consistently across measures (i.e., the PCL and 
NSI)? 
d. Are symptoms endorsed to a greater or lesser degree based on the type of 
measure (i.e., psychological vs. medical)? 
Question 3
Question 3 tested whether the level of consistency in a polytrauma clinic 
differed from the level of consistency in a PTSD clinic. 
a. Does one measurement setting demonstrate greater/lesser levels of 
consistency in reported symptoms than the other? 
Question 4
Question 4 assessed the extent to which self-reported PTSD symptoms, as 
measured by the PCL, varied over measurement occasions.
a. Do self-reported PTSD symptoms vary by measurement occasion? 
Question 5
Question 5 tested if self-reported PTSD symptoms depended on whether the 
veteran completed the PCL first in the PTSD clinic and then in the polytrauma clinic 
or vice versa. Stated differently, do those veterans who complete a PTSD assessment 
at time 1 and a polytrauma assessment at time 2 report greater/lesser levels of PTSD 
symptomology than those who complete polytrauma first and PTSD second? 




Question 6 tested for effects of context on self-reported PTSD symptoms. 
Specifically, regardless of the order of measurement occasions, do veterans report 
greater/lesser levels of PTSD symptomology when assessed in the PTSD clinic, a 
“mental health” or “psychological” setting versus the polytrauma clinic, a “medical” 
setting? 
a. Are symptoms endorsed to a greater or lesser degree when the assessment is 
administered in a psychological as opposed to a medical setting?
Question 7
Though the PCL is considered a diagnostic tool, it is typically used in clinical 
settings in tandem with a clinical diagnostic interview with both data sources 
contributing to the final diagnosis of PTSD. Generalizability Theory (“G Theory”) 
was used to assess the dependability of diagnoses of PTSD based solely on the PCL. 
a. Is the PCL dependable enough to make an absolute judgment (diagnosis) 
of PTSD based solely on its 17 items at one measurement occasion.
b. How many items and measurement occasions would be needed to make 
dependable diagnoses of PTSD using only the PCL.
METHODS
Participants 
The present study was approved by the University of Utah Institutional Review 
Board and the Research Review Committee of the George E. Wahlen Veterans Affairs 
Medical Center in Salt Lake City, Utah. Data were obtained from three independent 
retrospective medical chart reviews. For the sake of clarity, these will be referred to 
as DS1 (for dataset1), DS2, and DS3. DS1 was an existing database created from a 
retrospective chart review of 144 male OEF/OIF veterans who underwent a PTSD 
assessment at the Salt Lake City VA. These veterans had a diagnosis of military-related 
PTSD substantiated in their medical records. Sixty-one of these 144 also completed 
a polytrauma/TBI evaluation and have a co-occurring diagnosis of military-related 
mTBI noted in their records. Veterans were excluded if they met criteria for a 
moderate or severe brain injury. For a full description of DS1, refer to the study by 
Romesser and colleagues (Romesser et al., 2011). DS2 was obtained from an original 
retrospective chart review of 58 OEF/OIF/OND veterans who underwent both 
PTSD and polytrauma/TBI evaluations at the Salt Lake City VA. Further description 
is provided below. DS3 was an existing database created from a retrospective chart 
review of 529 OEF/OIF veterans who underwent TBI evaluations by the polytrauma 
teams at two different metropolitan VA medical centers, the Salt Lake City VA and 
the Michael E. DeBakey VA Medical Center in Houston, Texas. These veterans 
were referred to the polytrauma clinic following a positive screen on the VA’s TBI 
Clinical Reminder screening tool that was administered at an initial VA appointment. 
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Veterans were excluded if they met criteria for moderate or severe brain injury. For a 
full description of DS3, refer to the 2012 study by Romesser and colleagues (Romesser 
et al., 2012). 
DS2 was created by locating hard copies of assessment protocols from the 
PTSD and polytrauma clinics and compiling this information with data obtained 
from the Computerized Patient Record System (CPRS), the VA’s electronic medical 
records system. Fourteen members of the initial DS2 sample were dropped, leaving 
only 44 for final analyses. Four veterans were dropped due to significant missing 
data; 4 were dropped due to an inability to reliably interpret the assessment protocols 
due to multiple responses being endorsed simultaneously; 3 were dropped as a 
PTSD diagnosis was not substantiated in their medical records; 2 were dropped as 
they were classified with moderate to severe brain injury (rather than mild); and 
1 was dropped from analysis as they completed both assessments on the same day 
and it was impossible to determine the order in which these were completed from 
the information available in their medical records. Of the 4 veterans with missing 
data, CRPS records indicated that 2 were already service connected for PTSD at the 
time of their evaluation and thus were not required to complete the full assessment 
protocol, but rather went to the PTSD assessment clinic to seek referral for treatment. 
DS1 and DS2 were used to answer research question 1, DS2 and DS3 were 
used to answer research question 2, and all three datasets were used to answer 
research question 3. DS2 was used to answer research questions 4-7 as this was the 
only dataset that contained identical assessment protocols from the two distinct 





At the George E. Wahlen VA Medical Center in Salt Lake City, the PTSD 
Clinical Team (PCT) is an outpatient clinic specializing in the assessment, diagnosis, 
and treatment of PTSD and related psychiatric concerns. This clinic is housed in the 
outpatient mental health building on the VA campus, which is a separate building 
from the main medical hospital. Veterans are referred to the PTSD assessment group 
in a number of ways, including referral from their primary care provider or other 
provider/contact at the VA, referral during an inpatient psychiatric hospitalization, 
referral from a VA staff during their attendance at a postdeployment health re-
assessment (PDHRA), by a fellow veteran, friend, family member, or by self-referral. 
The PTSD assessment group is held once weekly and includes a group and individual 
component. Veterans complete assessment protocols in a large, open room with 
other Veterans, also presenting for PTSD evaluation. After completing the battery of 
paperwork, each veteran participates in a one-on-one clinical interview. The PCL is 
administered as one assessment within the 14-page Veterans Affairs Military Stress 
Treatment Assessment (VAMSTA; Fontana et al., 2006). In addition to testing 
for PTSD, the VAMSTA includes measures that evaluate depression, suicide risk, 
drug and alcohol use, health and medical problems, sleep, religious/spiritual life, 
Table 1. Sample Sizes, Measurement Occasions, Assessments, and Context
Dataset 1 Dataset 2 Dataset 3
Number of Cases 144 44 529
Number of Occasions 1 2 1
Assessments Given PCL, PHQ PCL, PHQ, NSI PCL, NSI
Measurement Context(s) PTSD PTSD & Polytrauma Polytrauma
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employment status, social life, and quality of life. 
Polytrauma Assessment Clinic
At the Salt Lake City VA, the polytrauma clinic is similar to the PCT in that 
it is an outpatient specialty clinic held one time per week; however, it differs from the 
PTSD clinic in many ways. This clinic is housed in the main medical hospital on the 
VA campus. Accessing the clinic requires that the individual walk past the entrance to 
the emergency department, past a primary care clinic, and the outpatient pharmacy. 
The clinic itself has a different feel from the PCT as it is a medical environment 
with private patient rooms containing medical examination tables. Referral to this 
clinic is limited in comparison to the PTSD clinic. Veterans are referred to this clinic 
only after screening positive on a brief TBI screen given in the course of a primary 
care or other medical or mental health appointment (including the PCT). The 
only group component of this clinic occurs when the maximum of four veterans in 
clinic are asked to gather in one room for a brief 5- to 10-minute psychoeducational 
presentation that describes TBI and typical recovery trajectories, common symptoms 
and problems following exposure to TBI, and common comorbidities. 
Veterans are asked to complete a battery of self-report assessment measures 
focused primarily on their history of exposure to potentially injurious events (e.g., 
falls, blasts, accidents, etc.) and related persistent symptoms, problems with pain, and 
the degree to which they are bothered by these problems. This battery also includes 
measures of PTSD (the PCL), depression (the Beck Depression Inventory), and 
postconcussive symptoms (the NSI). For the remainder of the clinic, veterans stay in 
their private exam room and are met by multiple members of the interdisciplinary 
Polytrauma Team. This assessment team typically includes a provider from each of 
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the following specialty areas: physical medicine/rehabilitation, neuropsychology, 
speech therapy, occupational therapy, physical therapy, social work/case management 
and nursing. During the course of this 4- to 5-hour assessment, veterans participate 
in multiple one-on-one clinical interviews to assess for TBI and related persistent 
symptoms. The staff briefly evaluates mental health concerns, gains a thorough 
medical history and understanding of complicating medical conditions, including 
brief vision and hearing evaluations, explores options for medication management as 
appropriate, and evaluates overall functioning.
Measures
The PTSD Checklist 
The PCL, developed at the National Center for PTSD, is a 17-item self-report 
measure of PTSD symptoms based closely on the criteria listed in the DSM-IV. 
Each symptom is rated in terms of severity. Respondents rate how much they were 
bothered by each item during the past month using a five-point scale that ranges from 
not at all (1) to extremely (5). Usually, a total score ranging from 17 to 85 is obtained 
by summing the response to each item. A total score of 50 is generally considered 
an appropriate cut off for making a PTSD diagnosis in treatment-seeking veterans 
(Forbes, Creamer, & Biddle, 2001; Weathers et al., 1993). The PCL has demonstrated 
high levels of diagnostic accuracy when evaluated against the gold standard structured 
interview measures such as the PTSD component of the Structured Clinical Interview 
for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1996) and the Clinician 
Administered PTSD Scale (CAPS; Blake et al., 1995), both at a single time point 
and over the course of treatment and follow-up (Forbes et al., 2001). The PCL 
has demonstrated strong test-retest reliability at 2-3 days (.96) and .88 at 1 week 
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(Blanchard et al., 1996; Ruggiero et al., 2003) and high levels of internal consistency 
that range between .94 (Blanchard et al., 1996) and .97 (Weathers et al., 1993). The 
PCL is one of the most widely used self-report measures of PTSD and has been shown 
to have excellent reliability and validity for a variety of populations (e.g., Blanchard, 
Jones-Alexander, Buckley, & Forneris, 1996; Cordova et al., 1995; Ruggiero, Del Ben, 
Scotti, & Rabalais, 2003; Weathers et. al., 1993). See McDonald and Calhoun (2010) 
for a review of the PCL’s diagnostic accuracy and Wilkins, Lang, and Norman (2011) 
for a summary of the PCL’s psychometric properties. 
The Neurobehavioral Symptom Inventory
The Neurobehavioral Symptom Inventory (NSI; Cicerone & Kalmar, 1995) 
is a 22-item self-report measure of postconcussive symptoms. Respondents are asked 
to rate how much they have been bothered during the past 2 weeks by each symptom 
using a five-point scale ranging from none (0) to very severe (4). The NSI includes 
three postconcussive symptom clusters composed of affective, somatic/sensory, and 
cognitive symptoms (Caplan, Ivins, Poole, Vanderploeg, Jaffee, & Schwab, 2010). 
These 22 items were derived from a larger structured clinical interview originally 
created by Levin et al. (1987) to assess common complaints subsequent to mTBI. 
Although the NSI is widely used within the VA Health Care System, relatively little 
is known about its psychometric properties. King and colleagues (2012) completed 
an investigation of the psychometric properties of the NSI and found that it 
demonstrated high internal consistency (total alpha = 0.95; subscale alpha = 0.88 to 
0.92) and that subscale total scores correlated highly with the total score (r = 0.88 to 
0.93). Their study found that the NSI was able to differentiate veterans with a history 
of TBI from those without, but was strongly influenced by variance associated with 
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probable PTSD, depression, and generalized anxiety. The measure is typically used as 
a screening tool, the results of which are reported in a qualitative manner rather than 
as a diagnostic tool that requires the calculation of a symptom cluster or total score 
indicative of the presence or absence of mTBI. Additionally, treatment providers can 
use the NSI as an assistive tool in clinical evaluations and interviewing as a quick 
snapshot of the postconcussive symptoms the veteran has endorsed, which then can 
be followed up on to get more information about onset, course, duration, severity, 
impairment, etc. 
The Patient Health Questionnaire 
The Patient Health Questionnaire (PHQ; Kroenke, Spitzer, & Williams, 
2001) developed by Pfizer Incorporated is comprised of nine items corresponding 
to the diagnostic criteria for major depressive disorder described in the DSM-IV-TR 
(American Psychiatric Association, 2000). This self-report is completed based on the 
past 2 weeks and asks raters to endorse symptoms on a four-point scale that ranges 
from not at all (0) to nearly every day (3). The total score can range from 0-27. The 
authors suggest five levels of severity: minimal (total score, 0 – 4); mild (total score, 5– 
9); moderate (total score, 10 - 14); moderately severe (total score, 15 –19); and severe 
(total score, 20– 27). The PHQ-9 has demonstrated a sensitivity and specificity of 
88% for major depression with scores at 10 or higher. This assessment has been found 
to be effective and useful in monitoring levels of severity of depression over time. 
Statistical Analysis 
Statistical analyses were conducted using IBM SPSS Statistics Version 21 
and the statistical package R. Veterans’ consistency in reporting on nearly identical 
items on the PCL and PHQ or NSI was assessed through Pearson Product Moment 
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correlations and intraclass correlation coefficient (ICC) reliability analyses. More 
specifically, correlational analyses  were calculated on items that measure sleep, 
concentration, and irritability from a single polytrauma evaluation and those items 
measuring sleep, concentration, and loss of interest from a single PTSD evaluation.  
Specific items on the PCL used in these correlational analyses include: item 13 
“trouble falling or staying asleep;” item 15 “having difficulty concentrating;” item 14 
“feeling irritable or having angry outbursts” and item 9 “loss of interest in activities 
that you used to enjoy.” Items on the NSI include: item 15 “difficulty falling or 
staying asleep;” item 13 “poor concentration, can’t pay attention, easily distracted;” 
and item 21 “irritability, easily annoyed.” Specific items from the PHQ include: item 3 
“trouble falling or staying asleep or sleeping too much;” item 7 “trouble concentrating 
on things, such as reading the newspaper or watching television;” and item 1 “little 
interest or pleasure in doing things.” To determine whether there were differences 
between measurement occasions, homogeneity of regression slopes were calculated 
using multiple regression. A two-period cross-over design in a fixed effects repeated 
measures analysis of variance (fixed effects RMANOVA) was used to evaluate 
veterans’ consistency in reporting on identical measures across time, measurement 
occasion, and the context of the measurement environment (i.e., the PTSD 
clinic, a “mental health” setting and the polytrauma clinic, a “medical” setting). 
Generalizability (G) theory is a statistical theory concerning the dependability or 
trustworthiness of generalization of behavioral measurements (Shavelson, Webb, 
& Rowley, 1989). A two-facet, fully crossed, random effects design with repeated 
measures ANOVA was used to evaluate the dependability of the diagnosis of PTSD 
based on the administration of the PCL.
RESULTS
Participants
The present study included data from 713 OEF/OIF/OND veterans with a 
median age of 28 years. They were predominantly male (96.5%), Caucasian (69.7%), 
married or partnered (53.4%), with high school diplomas or equivalent education 
(53.7%). DS1 did not include information regarding branch of service; however, 
DS2 and DS3 demographics suggest the majority of the sample served in the United 
States Army (Table 2 reports complete demographics). As DS2 was obtained from 
retrospective chart reviews for the current project, the demographic characteristics 
of that sample have not been reported previously. Participants in DS2 had a median 
age of 28 years, were exclusively male (100%), predominantly Caucasian (81.8%), 
married or partnered (61.4%), Army Veterans (52.3%), with high school diplomas 
or equivalent education (52.3%). Table 3 provides the mean total scores, standard 
deviations, and coefficient alphas for the PCL, NSI, and PHQ in all three datasets. 
Research Questions
Research Question 1 and Research Question 2
Intraclass and Pearson Product Moment correlation coefficients were calculated 
for individual items on the PCL, NSI, and PHQ to assess consistency of symptom 
reporting across measures. Pearson Product Moment correlations provide a basic linear 
correlation coefficient, whereas intraclass correlations attenuated the estimates of 
reliability to the extent that there were differences in mean levels of reported symptom 
severity. As indicated in Table 4, relatively strong correlations were demonstrated for 
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Table 2. Demographics
Dataset 1 Dataset 2 Dataset 3
M SD M SD M SD
Age 30.9 7.7 29.7 7.3 31.0 8.1
Dataset 1 Dataset 2 Dataset 3
n % n % n %
Gender
Male 144 100 44 100 504 95.3
Female – – – – 25 4.7
Race/Ethnicity
Caucasian 118 81.9 36 81.8 342 64.7
Hispanic 15 10.4 6 13.6 91 17.2
African American 2 1.4 2 4.5 79 14.9
Native American – – – – 3 0.6
Asian 2 1.4 – – 13 2.5
Pacific Islander – – – – 1 0.2
Other 3 2.1 – – – –
Unknown 4 2.7 – – – –
Marital Status
Married / Partnered 79 54.9 27 61.4 275 51.9
Divorced / Separated 24 16.7 7 15.9 108 20.4
Single / Never Married 28 19.4 10 22.7 142 26.8
Widowed – – – – 3 0.6
Unknown 9 6.3 – – 1 0.2
Education History
Less than High School – – – – 3 0.6
HS Diploma / Equiv. 78 54.2 23 52.3 282 53.3
Some College / Tech 12 8.3 12 27.3 200 37.8
Bachelor’s Degree 9 6.3 9 20.5 36 6.8
Some Graduate School – – – – 7 1.3
Unknown 41 28.5 – – 1 0.2
Military Branch of Service
Army – – 23 52.3 287 54.3
Air Force – – 4 9.1 21 4.0
Navy – – 4 9.1 33 6.2
Marine Corp – – 7 15.9 127 24.0
National Guard – – 6 13.6 59 11.2
Unknown 144 100 – – 2 0.3
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Table 3. Mean Scores, Standard Deviations, and Coefficient Alphas
Dataset 1 Dataset 2 Dataset 2 Dataset 3
(PTSD) (PTSD) (Polytrauma) (Polytrauma)
PCL
Mean Score 60.64 63.89 60.31 52.00
Standard Deviation 14.85 12.67 13.61 7.00
Cronbach’s Alpha 0.88 0.93 0.94 0.95
PHQ
Mean Score 15.34 13.75 – –
Standard Deviation 7.16 5.60 – –
Cronbach’s Alpha 0.82 0.86 – –
NSI
Mean Score – – 47.64 42.81
Standard Deviation – – 14.01 15.36
Cronbach’s Alpha – – 0.92 0.93
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Table 4. Correlation Results
Dataset 1 Dataset 2 Dataset 2 Dataset 3
N 144 44 44 529
Context PTSD PTSD Polytrauma Polytrauma
Sleep
Correlated Items A, B, C A, B A, B A, C A, C
ICC 0.66 0.77 0.73 0.81
Pearson 0.70 0.81 0.73 0.76
DF 137 43 43 487
P 0.000 0.000 0.000 0.000
Concentration
Correlated Items D, E, F D, E D, E D, F D, F
ICC 0.62 0.56 0.75 0.66
Pearson 0.63 0.56 0.74 0.64
DF 138 43 43 488
P 0.000 0.000 0.000 0.000
Irritability
Correlated Items G, H – – G, H G, H
ICC – – 0.76 0.71
Pearson – – 0.78 0.73
DF – – 43 506
P – – 0.000 0.000
Loss of Interest
Correlated Items I, J I, J I, J – –
ICC 0.58 0.74 – –
Pearson 0.58 0.75 – –
DF 137 43 – –
P 0.000 0.000 – –
A PHQ Item 13. “Trouble falling or staying asleep.”
B PHQ Item 3. “Trouble falling or staying asleep, or sleeping too much.”
C NSI Item 18. “Difficulty falling or staying asleep.”
D PCL Item 15. “Having difficulty concentrating.”
E PHQ Item 7. “Trouble concentrating on things, such as reading the newspaper or watching television.”
F NSI Item 13. “Poor concentration, can’t pay attention, easily distracted.”
G PCL Item 14. “Feeling irritable or having angry outbursts.”
H NSI Item 21. “Irritability, easily annoyed.”
I  PCL Item 9. “Loss of interest in activities that you used to enjoy.”
J  PHQ Item 1. “Little interest or pleasure in doing things.”
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those items measuring sleep. Moderate to strong correlations were seen for those items 
assessing concentration, irritability, and loss of interest. Little variation was noted 
between the Pearson and intraclass correlations and in all cases, the level of agreement 
between scales measured on the same day in the same clinical context remained 
moderate to strong. 
Research Question 3
Research Question 3 asked if the consistency of measurement in the PTSD 
clinic differed from the consistency of measurement in the polytrauma clinic.  
Separate multiple regression analyses were used to test for heterogeneity of regression 
or differential consistency between settings in self reports of problems sleeping and 
difficulties in concentration.  Note, the items assessing loss of interest and irritability 
were not included in these analyses as they were not assessed in both settings. There 
were no significant differences between the mental health (PTSD) and medical 
(polytrauma) settings in symptom reporting on items that measured sleep (β = .013, p 
= .720) or concentration (β = -.048, p = .184).
Research Question 4
The repeated measures ANOVA revealed no overall effect of measurement 
Occasion (F (1, 42) = 0.43, p = 0.52). However, given the archival nature of 
the dataset, there was no control over the length of interoccasion intervals. An 
examination of these revealed considerable variability in the interoccasion interval. 
Figure 1 shows that the distribution of days between measurement occasions ranged 
from 1 to 1810. 
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Research Question 5
A primary motivation for the present study was to determine if the severity of 
self-reported PTSD symptoms depends on whether the measurements are obtained in 
a medical or mental health context. In a two-period cross-over design, interpretation 
of the effect of Context requires that there be no differential carryover (Hills & 
Armitage, 1979). Differential carry-over is indicated when there is a between-group 
main effect of Order of test administration on the PCL scores (PTSD/mental health 
first versus polytrauma/medical first). The effect of Order was not significant (F (1, 
42) = 1.42, p = 0.24), indicating that differential carryover did not complicate the 
interpretation of the effect of Context.
Research Question 6
The repeated measures ANOVA revealed a significant effect of Context, F (1, 
42) = 5.79, p = .02, partial η2=.12. Contrary to predictions, the severity of symptoms 
on the PCL was higher in the PTSD clinic (M=63.34) than the polytrauma clinic 
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(M=58.37). The results of the repeated measures ANOVA that address Research 
Questions 4, 5, and 6 are summarized in Table 5.
Veterans measured first in a PTSD clinic reported the highest levels of PTSD 
symptoms. Reports were somewhat lower for veterans measured in the PTSD clinic 
on the second occasion. Conversely, veterans measured first in a polytrauma clinic 
had the lowest level of self-reported PTSD symptoms, but the severity of symptoms 
increased when veterans were queried in a polytrauma clinic after they had first 
been evaluated in a PTSD clinic. A test of the simple effect of Context at the first 
measurement occasion approached the conventional level of significance, t(43) = 
1.99, p = .053, partial η2 = .086. Simple effects of measurement occasion were not 
significant for veterans measured first in the PTSD clinic, F(1, 42) = 2.82, p = .100, or 
for veterans measured first in the polytrauma clinic, F(1, 42) = 3.23, p = .079. 
Research Question 7
The PCL is often used in combination with a clinical interview to determine if 
a veteran meets the criteria for PTSD. G Theory was used to assess the dependability 
of PTSD diagnoses based on the administration of the 17-item PCL on a single 
measurement occasion. Analyses assumed an absolute fixed cutoff for classifying 
veterans as either having PTSD or not. When decisions are based on a fixed cutoff, 
Table 5. Effects of Measurement Occasion, Context, and Order
Type III SS df Mean Sq. F p < .05 Partial η2
Within-Subjects
Occasion 19.32 1 19.32 0.43 0.52 –
Context 260.68 1 260.68 5.80 0.02 .12
Error 1887.90 42 44.95
Between-Subjects
Intercept 258597.02 1 258597.02 848.88 0.00 –
Order 430.93 1 430.93 1.415 0.24 –
Error 12794.56 42 304.63
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G Theory states that the error variance is the sum of all variances in the linear 
model except person variance(items, occasions, personXitems, personXoccasions, 
itemXoccasion, personXitemXoccasion, and error; Shavelson & Webb, 1991). The 
index of dependability was the ratio of person variance to the sum of person variance 
and error variance.  
The variance components for the generalizability study are reported in Table 6. 
The generalizability analysis yielded a dependability (Φ) of .423. Thus, only 42.3% of 
the variance in PCL total scores was dependable. An interesting benefit of G theory 
is that it allows for “what-if” studies, in which it is possible to estimate what the 
dependability of a measure could be with different numbers of items or occasions. In 
this case, manipulations of the number of items and occasions, even up to 100,000, 
produced negligible improvement in dependability (Φ = .506). These manipulations 
had little effect on Φ because they had no effect on the residual variance 
component. To determine if unmodeled variance in PCL scores associated with 
context affected the estimates of variance components for the generalizability 
study, the analyses were repeated using only the larger of the two groups that first 
completed the PCL in the PTSD clinic (n=32). The effects on variance estimates 
were negligible. 





Person x Item 0.29
Person x Occasion 0.15
Item x Occasion 0.00
Residual 0.42
DISCUSSION
Consistency of Item-Level Symptom Endorsement
The Pearson Product Moment and intraclass correlation results from the PTSD 
and polytrauma clinics demonstrate moderate to strong correlations between items 
that assess sleep, concentration, irritability, and loss of interest. This suggests veterans 
endorse these symptoms similarly across measures within a single measurement 
occasion. The strongest correlation was found on the items measuring sleep within 
the polytrauma clinic (PCL 13, NSI 18, ICC = .81). This result is not necessarily 
surprising as these two items are the most synonymous of those being tested. It is 
likely that the minor difference in wording (e.g., “trouble” and “difficulty” falling or 
staying asleep) is negligible. Further, both assessments ask veterans to report their level 
of distress on a five-point scale with response anchors focused on severity and intensity 
of symptoms rather than frequency of symptom occurrence. It is interesting, given the 
high level of similarity between the PCL and NSI sleep items that the correlation is 
not higher. 
The lowest intraclass correlation, although still moderately strong, was found 
on the concentration items within the PTSD clinic (PCL 15, PHQ 7, ICC = .56). Of 
the items being tested, these two are the most dissimilar in terms of wording. The 
PHQ item is more specific than the PCL item, and it includes the example, “reading 
a newspaper or watching television.” It is possible that the added specificity of the 
item contributes to variance in responses between the two instruments. Additionally, 
unlike the PCL and NSI, the PHQ asks veterans to respond to how much they 
have been bothered by symptoms in terms of frequency, rather than severity. This 
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difference in response scales also may contribute to variance in responses to items on 
the PCL and PHQ. Further, sleep disturbances may be an easier construct to quantify 
and associate with a subjective level of distress than one’s ability to concentrate. It 
is relatively simple to quantify the number of hours of sleep one gets each night, 
how long it takes them to fall asleep, and how many times they wake in the night, 
in comparison to trying to accurately evaluate problems with concentration such as 
the number of times an individual gets distracted or notices their mind wandering. 
Additionally, the concentration items may be more highly correlated in the 
polytrauma setting as veterans may associate concentration as a symptom of mTBI 
rather than depression or PTSD and thus may be more likely to endorse elevated 
concentration problems in the  medical setting. 
In this case, it is difficult to know what contributed to the level of overall 
consistency. Overall both settings demonstrated moderate to strong consistency 
across items, with slightly more, although not statistically significantly greater, in the 
medical setting. However, this result may be an artifact of the structural similarity 
of the PCL and NSI compared to the PCL and PHQ, rather than the measurement 
context itself. Given the similarity in items and the close temporal proximity in 
completion of the measures, it is encouraging that the results demonstrated moderate 
or strong correlations across measures and settings, which indicates consistency in 
item-level symptom endorsement. 
The Influence of Measurement Occasion, Order, and Context
Interestingly, there was no main effect for measurement occasion. Since 
there was no control over interoccasion intervals, variance in time intervals between 
measurement occasions would appear as person X occasion interaction variance 
or error, reducing the sensitivity of the statistical test for the effects of occasions. 
Despite the variance in interoccasion intervals, there appeared to be some evidence 
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of differential regression effects. Veterans measured in the mental health setting on 
the first occasion had high PCL scores, whereas veterans measured in the mental 
health setting on the second occasion regressed downward and were less extreme. 
The opposite effect was observed for veterans measured in the medical setting. Those 
scores were relatively low on the first occasion and were elevated on the second. 
Thus, there was no mean effect of occasion on PCL scores, but there was evidence of 
negative change for some veterans and positive change for others. 
It is also possible that many of the veterans in this sample were not engaged in 
any sort of treatment or intervention and thus may not have had significant impetus 
for PTSD symptoms to change in the interval between measurement occasions. 
Additionally, it is possible that veterans were engaged in treatment, but not necessarily 
a trauma-focused evidence-based therapy such as Prolonged Exposure or Cognitive 
Processing Therapy, which were part of VA-wide rollouts, beginning in 2007 under 
the direction of the VA Office of Mental Health Services. Data regarding treatment 
were collected as part of the retrospective chart review. Unfortunately, many of the 
medical records were vague and thus it was challenging to provide a clear indication 
of the amount of treatment veterans received, only the types of treatments. Finally, 
Forbes et al. (2001) compared the PCL to the CAPS at pre- and posttreatment. They 
found that the PCL provided a more conservative estimate of change (8.4%) than the 
CAPS (17.5%). In the absence of a large shift in symptoms, many veterans may report 
similar levels of severity on the PCL across time. 
When considering the null effect of measurement occasion and the significant 
effect of context, it is appropriate to consider the possibility of inaccurate presentations 
and symptom endorsements during testing. It is also important to consider the 
symptoms evaluated on the PCL, some of which are non-specific in nature (e.g., 
sleep, concentration, loss of interest, irritability) and may be elevated due to other 
psychiatric or medical health concerns. Approximately 85% of the sample endorsed 
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PTSD symptoms at or above the recommended cut-off of 50, with many significantly 
elevated scores suggestive of severe PTSD symptomology. Although a large body of 
literature exists concerning the detection of exaggerated PTSD symptoms, self-report 
measures, such as the PCL, are ineffective in detecting symptom exaggeration (Guriel 
& Gremouw, 2003).
Related to possible symptom overreporting, the potential for new or continued 
secondary gain must be considered, particularly as many of these participants are 
recently returned veterans who will be relatively new to the VA Health Care System. 
For some, the PTSD or polytrauma clinics may have been their first exposure to 
the VA. Elements of secondary gain can include financial incentives such as service 
connection, access to treatment services, avoiding criminal charges and related 
consequences, and for some, receiving recognition for military service (Bianchini, 
Mathias, & Greve, 201; Elhai et al., 2012; Greiffentstein & Baker, 2008). Further, 
it has been argued that the service connection/disability program within the VA can 
have unintended consequences of creating, promoting, or even accentuating problems 
or illness due to the structure of the system and the requirements for receiving benefits 
(Howe, 2009; Mossman, 1996; Sayer, Spoont, Nelson, Clothier, & Murdoch, 2008). 
Although an effect of context was predicted, the finding that reports of PTSD 
symptoms were higher in the mental health clinic than in the medical setting are 
contradictory to those hypothesized. Divergent to this result, a body of literature 
suggests that OEF/OIF/OND veterans are more likely to accept more medically 
based diagnoses such as TBI, than they are mental health diagnoses such as PTSD 
or depression due to cultural factors and stigma (Brenner, Vanderploeg, & Terrio, 
2009; Hoge et al., 2004; Kilbourne, Keyser, & Pincus, 2010; Osterman & de Jong, 
2007). Further, there may be a belief that mTBI is due to an injurious event and thus 
is not the fault of the individual, whereas some may view PTSD or other psychiatric 
concerns to be the mark of characterological flaw, weakness, or personal shortcoming. 
46
Further anecdotal reports indicate that veterans may be more likely to follow through 
with treatment recommendations or referrals for TBI-related intervention (e.g., 
neuropsychological testing, rehabilitation services such as physical, occupational, and 
speech therapy, and cognitive remediation and cognitive aids) than they are for mental 
health services (e.g., individual or group psychotherapy, psychotropic medications; 
Brenner et al., 2009). 
Consistent with the results from veterans in the present study who were first 
assessed in the medical setting, several studies have found an increase in PTSD and 
postconcussive symptom endorsement over time (Belanger et al., 2009; Milliken et 
al., 2007). Several explanations have been suggested to explain these findings. First, 
it has been proposed that physiological changes that persist following mTBI such as 
vestibular changes, hearing loss, and tinnitus may result in increased anxiety over 
time. Additionally, it is possible that the longer veterans are home from deployment 
and continue transitioning back into a civilian lifestyle, they may become more 
aware of symptoms (Belanger et al., 2009). Further, screening and assessment within 
a polytrauma clinic setting is typically remote in time from the injury event(s) and 
one’s accuracy of reporting decreases over time (Hoge, 2010; Vanderploeg & Belanger, 
2013). Of important note, mTBI is not a progressive disease; the symptoms to no 
worsen with time, but rather are expected to improve and typically remit within 
hours to months of the injury (Vanderploeg & Belanger, 2013). Given natural course 
of recovery from mTBI, if PCS-like symptoms exist that are chronic in nature, they 
are most likely unrelated to the mTBI, but rather to other factors such as PTSD or 
other psychiatric concerns, chronic pain, substance use, or poor sleep. Additionally, 
it is important to remember that some of these symptoms are non-specific in nature 
and are, in fact, normal and expected among postdeployment combat veterans (Hoge, 
2010). 
It is also quite possible that the clinical context primes veterans to be more 
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or less sensitive to certain types of items, even prior to their arrival at the clinic. For 
example, veterans who report to a PTSD clinic will know that they are attending 
an appointment intended to evaluate their PTSD symptoms, and they may be more 
prepared to endorse these sorts of symptoms. Further, if a veteran is willing to seek 
treatment and/or accept a referral from a treatment provider or loved one, it is likely 
that stigma is not a concern, or may be a concern that pales in comparison to their 
desire to get help for their symptoms. Relatedly, veterans who complete both PTSD 
and polytrauma assessments may be atypical of the majority of veterans who seek 
treatment at the VA. Conversely, a veteran with an appointment in a polytrauma 
clinic may be focused more on their cognitive and sensory/somatic complaints, or 
other factors such as chronic pain, than psychiatric symptoms. Depending on the 
severity of symptoms and other potentially complicating comorbidities, it is possible 
that veterans in the polytrauma clinic are preoccupied with more medical/physical 
complaints. 
Dependability of the PCL
In clinical practice settings, the PCL is most often used as a self-report 
measure of PTSD symptoms to inform a clinical interview. A limitation of the current 
study is that the PCL was the only source of diagnostic information available for 
PTSD. As such, the author wanted to assess how much confidence should be placed 
on the PCL that it will produce the same diagnostic decisions if it were administered 
on any one of multiple occasions. Generalizability theory provided an opportunity 
to explore the effects of increasing the number of items or measurement occasions on 
the dependability of diagnoses based on the PCL. This exercise can provide useful 
information regarding the dependability of a measure and have possible implications 
for clinical practice. 
At the outset of the present study, the dependability of the PCL for the current 
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sample was an interesting question. However, the current dataset was inadequate 
to answer the question. The present sample had a restricted range, over 85% of the 
total scores exceeded the recommended cutoff of 50 for a diagnosis of PTSD. Indeed, 
several cases were dropped from the sample because those veterans ultimately were not 
diagnosed with PTSD. The restriction of range precluded a reasonable assessment of 
the usefulness of the PCL for identifying veterans with PTSD. 
Limitations and Directions for Future Research
There are several limitations to this study that require acknowledgment. The 
sample size used for the majority of analyses was small. Future research should include 
larger datasets with greater variability in test scores to ensure more generalizable 
results. The current data did not include service connection status at any time point. 
This information will be important given the literature concerning over-reporting 
both PTSD and postconcussive symptoms for the purposes of secondary gain. 
Although chart reviews included a preliminary evaluation of treatment between 
measurement occasions, given the considerable variance in interinterval occasions, 
it will be necessary to have greater control over what types and amount of treatment 
interventions veterans receive between measurement occasions. Romesser and 
colleagues tested for treatment effects by evaluating both the influence of earlier 
TBI treatment and the use of psychotropic medications within 30 days of the PTSD 
assessment and found no significant effects for either (Romesser et al., 2011). In 
addition to knowing the time between measurement occasions, it will be useful to 
note the time since injury for mTBI. The majority of the sample included in the 
present study have remote injuries (6 months to 1 year on average) and as there is 
a large body of literature on the expected resolution of symptoms and course of 
recovery (Belanger, Curtiss, Demery, Lebowitz, & Vanderploeg, 2005; Carroll et al., 
2004; Vanderploeg & Belanger, 2013). Having a sense of the time since injury  could 
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provide some insight into the potential severity of symptoms attributable to mTBI. 
Controlling for time between interval occasions may provide useful 
information regarding the trajectory of veterans’ self-reported PTSD and 
postconcussive symptoms following a single measurement occasion. It could also 
prove beneficial to collect additional clinical information concerning participants 
such as the presence (or absence) of other diagnoses, including depression, anxiety 
disorders, adjustment disorder, substance use disorders, and chronic pain as each of 
these have some similar symptoms to those of PTSD and postconcussive symptoms. 
Demographic, diversity, and cultural factors such as age, ethnicity, gender, and 
other factors should be considered. Given the high prevalence rates of military 
sexual trauma (MST) among returning service members and veterans, it would 
be interesting to evaluate, what, if any, influence the presence of MST has on the 
outcome of results. Chart review should also include an investigation of referral source 
as there may be differences among those who are self-referred for a PTSD assessment 
as compared to those who are referred by a physician or other treatment provider. 
Conclusions
Within the VA Health Care System, PTSD is routinely assessed in both 
mental health settings, including PTSD specialty clinics, and medical settings, 
such as polytrauma clinics, yet this is the first study to the author’s knowledge that 
investigated the reliability of the PCL when administered in mental health and 
medical settings on multiple measurement occasions. Research designed to optimize 
the diagnostic accuracy, reliability, and clinical utility of assessment for PTSD, mTBI 
history, and PCS are important (Carlson et al., 2009; Iverson, 2012). For veterans, 
diagnosis directly influences the type of treatment(s) they may receive and the 
compensation benefits they may be eligible for. The present study revealed significant 
differences between mental health and medical contexts in veterans’ reports of  PTSD 
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symptoms. Given the large numbers of recently returning OEF/OIF/OND veterans 
and the high prevalence rates of co-occurring PTSD and mTBI, these results call 
for continued investigation of the reliability of commonly used assessment measures 
when administered in different contexts. The optimization of assessment protocols 
for this new generation of veterans will provide better opportunity to ensure accurate 
diagnoses, and in turn, can improve the overall care these service members  receive. 
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